Tepid earnings growth, the mislaid $17.2m; cited that takeover rumours pushed her up recently; finally, they rate the stock as being "expensive". FYI.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game